| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phospholipase A2 receptor 1 | 0.633 | 0.577 | 3.2E-30 |
|
disease | 0.100 | None | 0.983 | 58 | 3 | 2010 | 2020 | ||||||||
|
phospholipase A2 group IB | 0.468 | 0.846 | 1.0E-10 |
|
disease | 0.100 | None | 0.957 | 47 | 0 | 2010 | 2020 | ||||||||
|
phospholipase B1 | 0.488 | 0.846 | 1.7E-72 |
|
disease | 0.100 | None | 0.957 | 46 | 0 | 2010 | 2020 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 0.475 | 0.846 | 0.94 |
|
disease | 0.100 | None | 0.957 | 46 | 0 | 2010 | 2020 | ||||||||
|
thrombospondin type 1 domain containing 7A | 0.644 | 0.654 | 1.00 |
|
disease | 0.100 | None | 0.974 | 39 | 0 | 2017 | 2020 | ||||||||
|
IgA nephropathy | 0.524 | 0.808 |
|
disease | 0.100 | None | 0.969 | 32 | 0 | 1996 | 2020 | |||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.390 | None | 1.000 | 14 | 0 | 1992 | 2018 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.470 | None | 1.000 | 9 | 2 | 2001 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 1998 | 2018 | ||||||||
|
actinin alpha 4 | 0.508 | 0.808 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2014 | 2019 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2005 | 2020 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2005 | 2020 | ||||||||
|
NPHS1 adhesion molecule, nephrin | 0.597 | 0.615 | 2.5E-14 |
|
disease | 0.230 | None | 1.000 | 4 | 0 | 2002 | 2019 | ||||||||
|
LDL receptor related protein 2 | 0.491 | 0.846 | 1.00 |
|
disease | 0.230 | None | 0.750 | 4 | 0 | 1989 | 2005 | ||||||||
|
RNA binding motif protein 45 | 0.383 | 0.846 | 2.1E-10 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1995 | 2017 | ||||||||
|
transient receptor potential cation channel subfamily C member 6 | 0.514 | 0.692 | 3.0E-07 |
|
disease | 0.030 | None | 0.667 | 3 | 1 | 2007 | 2013 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1983 | 2012 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1997 | 1999 | ||||||||
|
mannose binding lectin 2 | 0.390 | 0.846 | 2.7E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2018 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2017 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
NAD(P)H quinone dehydrogenase 1 | 0.434 | 0.885 | 1.2E-09 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2010 | 2019 |